Literature DB >> 25920402

The role of heart rate may differ according to pathophysiological setting: from SHIFT to SIGNIFY.

Roberto Ferrari1, Kim M Fox2.   

Abstract

Year:  2015        PMID： 25920402     DOI： 10.1093/eurheartj/ehv150

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  6 in total

1.  Ivabradine (Corlanor) for Heart Failure: The First Selective and Specific I f Inhibitor.

Authors:  Sally Tse; Nissa Mazzola
Journal:  P T       Date:  2015-12

Review 2.  Heart rate reduction in coronary artery disease and heart failure.

Authors:  Roberto Ferrari; Kim Fox
Journal:  Nat Rev Cardiol       Date:  2016-05-26       Impact factor: 32.419

Review 3.  Current Role of Ivabradine in Stable Coronary Artery Disease Without Heart Failure.

Authors:  Mateo Porres-Aguilar; Oscar C Muñoz; Aamer Abbas
Journal:  Curr Cardiol Rep       Date:  2016-02       Impact factor: 2.931

Review 4.  Ivabradine in Cardiovascular Disease Management Revisited: a Review.

Authors:  Christopher Chen; Gurleen Kaur; Puja K Mehta; Doralisa Morrone; Lucas C Godoy; Sripal Bangalore; Mandeep S Sidhu
Journal:  Cardiovasc Drugs Ther       Date:  2021-01-07       Impact factor: 3.727

5.  Heart Rate Reduction With Ivabradine Protects Against Left Ventricular Remodeling by Attenuating Infarct Expansion and Preserving Remote-Zone Contractile Function and Synchrony in a Mouse Model of Reperfused Myocardial Infarction.

Authors:  Daniel M O'Connor; Robert S Smith; Bryan A Piras; Ronald J Beyers; Dan Lin; John A Hossack; Brent A French
Journal:  J Am Heart Assoc       Date:  2016-04-22       Impact factor: 5.501

6.  Clinical presentation and management of stable coronary artery disease in Austria.

Authors:  Otto Pichlhöfer; Manfred Maier; Roza Badr-Eslam; Robin Ristl; Magdalena Zebrowska; Irene M Lang
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.